Who’s Hired? Apotex Names New US President & CEO
Viatris Appoints Head Of Capital Markets; Akorn Has A Fresh Board
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.
You may also be interested in...
Siegfried has completed the acquisition of two Spanish manufacturing facilities from Novartis, in a move that will significantly enhance the Swiss CDMO’s capacity.
Viatris, the combination of Mylan and Pfizer’s Upjohn unit, launched on 16 November. The culmination of almost 16 months of work, the transaction faced many hurdles, not least the devastating effects of the novel coronavirus pandemic. Generics Bulletin has collated every step of the deal in chronological order, spanning its 476-day history.
Eagle Pharmaceuticals is looking increasingly likely to launch its generic of Endo’s $700m Vasostrict (vasopressin) injectable ‘at risk’ amid FDA priority review for its ANDA and a delayed trial on Vasostrict intellectual property, set to take place in January next year.